Prior notification of a concentration (Case COMP/M.4314 — Johnson %amp% Johnson/Pfizer Consumer Healthcare) Text with EEA relevance Prior notification of a concentration (Case COMP/M.4314 — Johnson %amp% Johnson/Pfizer Consumer Healthcare) (2006/C 258/08) (Text with EEA relevance) 1.
On 19 October 2006, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [1] by which the undertaking Johnson %amp% Johnson (%quot%J%amp%J%quot%, USA), acquires within the meaning of Article 3(1)(b) of the Council Regulation control of part of the undertaking Pfizer Inc. (%quot%Pfizer%quot%, USA), namely Pfizer's entire consumer healthcare division, Pfizer Consumer Health Care (%quot%PCH%quot%, USA), by way of purchase of shares and assets. 2.
Observations can be sent to the Commission by fax (fax No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4314 — Johnson %amp% Johnson/Pfizer Consumer Healthcare, to the following address: European Commission Directorate-General for Competition Merger Registry J-70 B-1049 Bruxelles/Brussel [1] OJ L 24, 29.1.2004, p. 1. --------------------------------------------------
